Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05537454 · ClinicalTrials.gov registry record

Maternal Stress, Milk Composition, and Preterm Neurodevelopment

A clinical trial of Prematurity, sponsored by University of Minnesota.

Recruiting
Registry status
120
Enrollment target
1
Study location

NCT05537454: Recruiting study of Prematurity, sponsored by University of Minnesota.

NCT05537454 is a study of Prematurity that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 120 participants, below the 205-participant average among 21 other Prematurity trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05537454, a study of Prematurity, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

This study explores the associations between maternal stress, breastmilk composition, and feeding and neurodevelopment for preterm infants in the NICU and at 4 months corrected age.

Primary Outcome

total volume (mL)

Conditions Studied

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2022-12-09
Est. Completion 2030-07-31
University of Minnesota

966 total trials

What NCT05537454 shows while recruiting

NCT05537454 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 205-participant average among 21 other Prematurity trials with a reported enrollment target (41% lower).

The record links to 1 condition, with Prematurity appearing as the primary indexed condition, and to 0 interventions.

NCT05537454 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT05537454 about?

NCT05537454 is a clinical study titled "Maternal Stress, Milk Composition, and Preterm Neurodevelopment". This study explores the associations between maternal stress, breastmilk composition, and feeding and neurodevelopment for preterm infants in the NICU and at 4 months corrected age.

What is the current status of trial NCT05537454?

This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2022-12-09. Estimated completion is 2030-07-31.

What conditions does trial NCT05537454 study?

This clinical trial studies the following conditions: Prematurity.

Who is sponsoring clinical trial NCT05537454?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05537454 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prematurity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05537454's enrollment target sits among peer trials

120 8th of 21 higher than 13 of 21 other Prematurity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prematurity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05537454, the US trial registry maintained by the National Library of Medicine. NCT05537454 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.